权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Functional analysis of malignant brain tumor related gene <h-neu> and development of a novel molecular tageting therapy based on the h-neu gene function

恶性脑肿瘤相关基因<h-neu>的功能分析及基于h-neu基因功能的新型分子标记疗法的开发

基本信息

批准号：
17591520
负责人：
NAKAMURA Hideo
金额：
$ 1.92万
依托单位：
Kumamoto University
依托单位国家：
日本
项目类别：
Grant-in-Aid for Scientific Research (C)
财政年份：
2005
资助国家：
日本
起止时间：
2005 至 2006
项目状态：
已结题

项目摘要

We have been investigated about the analysis of the function in the product of a novel gene < h-neu>. We also have tried several experiments to investigate how this gene prduct functions in the malignant glioma cells. First, we made a new antibody to recognize the epitope of the h-neu protein by ourselves. Since we could confirm that this antibody worked in immunhistochemistry, we tried to stain the tumor samples in every grade of gliomas. However, we could not find out the significant differences in the sensitivity of the staining, therefore, we concluded that the expression level of h-neu in glioma was not so high. Next, we performed a Real-Time PCR in every grade of glioma samples. The expression of the mRNA of h-neu in malignant glioma was low compared as those of low grade gliomg. To investigate how the reduction of the product of h-neu affect the growth rate of malignant gliomas, we made a siRNA of h-neu and performed the transfection of it to several glioma culture cells. The reduction of the growth rate due to the transfection of h-neu siRNA was various in glioma cell lines. We considered that the variety of the reduction rate of growth in glioma cell lines was basically due to the native expression of h-neu in each cell lines, therefore, we performed the Nothern blot analysis and measured the expression level of h-neu in each cell lines. However the there was no relation between the expression of h-neu and the reduction rate of the growth due to siRNA in glioma cell lines. We considered that we should attempt to investigate the function of h-neu protein, we have started the functional analysis of h-neu using the proteomix procedure. We are now preparing the glioma cell line in which h-neu was overexpressed. Furthermore, we are still planning several experiments to investigate the h-neu function. We would like to know the normal function of h-neu and after that we would like to try to know the meaning 3 of h-neu function in glioma cell lines.

我们对一个新基因产物的功能分析进行了研究< h-neu>。我们还尝试了几个实验来研究该基因产物在恶性胶质瘤细胞中的作用。首先，我们自制了一种新的抗体来识别h-neu蛋白的表位。由于我们可以证实这种抗体在免疫组织化学中起作用，我们试图对每个级别的胶质瘤的肿瘤样本进行染色。然而，我们没有发现染色敏感性的显著差异，因此，我们得出结论，h-neu在胶质瘤中的表达水平不是很高。接下来，我们在每个级别的胶质瘤样本中进行了实时PCR。h-neu mRNA在恶性胶质瘤中的表达较低。为了研究h-neu产物的减少如何影响恶性胶质瘤的生长速度，我们制备了h-neu的siRNA，并将其转染到几种胶质瘤培养细胞中。由于转染h-neu siRNA导致的生长速率的降低在胶质瘤细胞系中是不同的。我们认为胶质瘤细胞系中生长下降率的变化基本上是由于h-neu在每个细胞系中的天然表达，因此，我们进行了Nothing印迹分析并测量了每个细胞系中h-neu的表达水平。而h-neu的表达与siRNA对胶质瘤细胞生长的抑制率无关。我们认为我们应该尝试研究h-neu蛋白的功能，我们已经开始使用蛋白质组学方法对h-neu进行功能分析。我们现在正在制备h-neu过表达的神经胶质瘤细胞系。此外，我们仍在计划几个实验来研究h-neu函数。我们希望了解h-neu的正常功能，并在此之后，我们希望尝试了解h-neu功能在胶质瘤细胞系中的意义。

项目成果

期刊论文数量（24）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Pediatric primary CNS lymphoma : longterm survival after treatment with radiation monotherapy.

儿童原发性中枢神经系统淋巴瘤：采用放射单一疗法治疗后的长期生存。

DOI：
发表时间：
2007
期刊：
Acta Neurochir (Wien). 149(3)
影响因子：
0
作者：
S.Yano;M.Morioka et al.;Nakamura H. et al.;Makino K. et al.
通讯作者：
Makino K. et al.

Comparative clinical study of the anti-emetic effects of oral ramosetron and injected granisetron in patients with malignant glioma undergoing ACNU chemotherapy.

口服雷莫司琼与注射格拉司琼对ACNU化疗恶性胶质瘤患者止吐效果的比较临床研究

DOI：
发表时间：
2005
期刊：
Neurologia Medico Chirurgica(Tokyo) 45(6)
影响因子：
0
作者：
K.;Makino;M.;Kochi;H.;Nakamura;J.;Kuroda;Y.;Honda;Y.;Ushio;J.;Kuratsu;Yano S.et al.
通讯作者：
Yano S.et al.

Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience

DOI：
10.3171/jns.2006.105.4.538
发表时间：
2006-10-01
期刊：
JOURNAL OF NEUROSURGERY
影响因子：
4.1
作者：
Yano, Shigetoshi;Kuratsu, Jun-ichi
通讯作者：
Kuratsu, Jun-ichi

Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan

DOI：
10.1016/j.surneu.2006.05.055
发表时间：
2006-11-01
期刊：
SURGICAL NEUROLOGY
影响因子：
0
作者：
Makino, Keishi;Nakamura, Hideo;Kuratsu, Jun-ichi
通讯作者：
Kuratsu, Jun-ichi

脳腫瘍の外科 -脳腫瘍の手術の進歩と限界-

脑肿瘤手术-脑肿瘤手术的进展和局限性-

DOI：
发表时间：
2006
期刊：
影响因子：
0
作者：
S.Yano;M.Morioka et al.;Nakamura H. et al.;Makino K. et al.;Nakamura et al.;Makino K. et al.;Nakamura H.et al.;Makino K.et al.;Nakamura H. et al.;Makino K. et al.;Hayashida. et al.;Kai.et al.;Makino K. et al.;Yano S.et al.;Hayashida Y et al.;Kai Y.et al.;Matsumoto J. et al.;Nakamura H.et al.;Makino K.et al.;Hayashida.et al.;Kai.et al.;Nakamura H.et al.;Makino K.et al.;Yano S.et al.;Matsumoto J.et al.;中村英夫
通讯作者：
中村英夫